NCI-designated Basic Laboratory Cancer Centers get research done—efficiently

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Having had the honor and pleasure to lead an NCI-designated cancer center for several years, I would like to share my thoughts on this small yet unique set of institutes and their value to NCI and the nation. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Ze’ev Ronai, PhD
Director, Translational Research Institute, Professor, Department of Biomedical Sciences and the Jim and Eleanor Randall Department of Surgery, Scientific director, Surgical Melanoma Research Program, Randall Department of Surgery, Cedars Sinai Medical Center
Table of Contents

YOU MAY BE INTERESTED IN

Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers. 

In the first meeting of the National Cancer Advisory Board since the inauguration of President Donald Trump, NCI Principal Deputy Director Douglas R. Lowy addressed many of the burning questions the oncology field has for the institute. On indirect costs: NCI will continue to use previously negotiated and approved indirect cost rates, with the exception...

Ze’ev Ronai, PhD
Director, Translational Research Institute, Professor, Department of Biomedical Sciences and the Jim and Eleanor Randall Department of Surgery, Scientific director, Surgical Melanoma Research Program, Randall Department of Surgery, Cedars Sinai Medical Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login